CLUSTER filed Jun 22, 2026 at 19:59 ET
Five Oruka Therapeutics insiders, including the CEO, CMO, COO, General Counsel, and SVP Finance, sold a total of $396K in open-market shares over a 7-day window. The CEO sold $120K at $69.69, the CMO sold $112K at $68.38, and the COO sold $42K at $69.69. The cluster is notable for involving the entire C-suite (CEO, CMO, COO) plus the General Counsel and finance head, but the total dollar value is only ~0.009% of the $4.4B market cap, well below the 0.1% threshold for materiality. The sales appear to be routine, likely driven by shared blackout-window opening or 10b5-1 plan timing, not a coordinated bearish signal.